Superstring Capital Management LP has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $151 Billion distributed in 37 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cytokinetics Inc with a value of $19.6B, Nkarta, Inc. with a value of $12.9B, 89bio, Inc. with a value of $11B, Bridge Bio Pharma, Inc. with a value of $10.9B, and Savara Inc with a value of $10.3B.

Examining the 13F form we can see an increase of $11.1B in the current position value, from $140B to 151B.

Superstring Capital Management LP is based out at New York, NY

Below you can find more details about Superstring Capital Management LP portfolio as well as his latest detailed transactions.

Portfolio value $151 Billion
Healthcare: $139 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 37
  • Current Value $151 Billion
  • Prior Value $140 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 17 stocks
  • Additional Purchases 12 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 7 stocks
Track This Portfolio

Track Superstring Capital Management LP Portfolio

Follow Superstring Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Superstring Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Superstring Capital Management LP with notifications on news.